Skip to content

Foot Orthoses in Patellofemoral Pain Syndrome: a Prospective Randomized Study of Morpho-specific Versus Placebo Orthoses

Foot Orthoses in Patellofemoral Pain Syndrome: a Prospective Randomized Study of Morpho-specific Versus Placebo Orthoses

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02250144
Enrollment
80
Registered
2014-09-26
Start date
2015-06-30
Completion date
2016-08-31
Last updated
2015-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral Pain Syndrome

Keywords

Patellofemoral pain syndrome, Feet orthoses, KOOS

Brief summary

Patellofemoral pain syndrome is one of the most common musculoskeletal disorders. It is defined as an anterior knee pain. Its origin is a conflict during patellar tracking, due to patellofemoral malalignment and soft tissue overload. A few recent studies seem to show a benefit of prefabricated feet orthoses in patellofemoral pain syndrome, alone or in association with rehabilitation. However, no one has analyzed the outcome of morpho-specific foot orthoses in a prospective randomized study. The purpose of this prospective randomized study is to compare clinical outcomes in daily living and in sports activities, between morpho-specific and placebo foot orthoses. Morpho-specific foot orthoses are designed according to the patient's morphotype. They are intended to correct structural defects of the hindfoot, midfoot and forefoot, in the aim to correct abnormal overload during patellofemoral tracking.

Interventions

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
12 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Male or female aged 12-40 years * Patellofemoral pain syndrome * Patient affiliated to a social protection regime * Patient who signed an informed consent * For teenagers with no complete growth and muscular maturation, failure of appropriate rehabilitation during minimum 2 months * Patient informed of the results of the prior medical examination * Normality (no sign of osteoarthritis) of the knee radiographs * Ability to read and understand French

Exclusion criteria

* Knee osteoarthritis * Systemic disease * Inflammatory rheumatism disease * Unstable knee * Prior patellofemoral dislocation * Osteochondrosis * Referred pain from a hip or spine disease (particularly proximal femoral epiphysiolysis in the teenagers) * A history of patellar trauma * A history of knee surgery * Meniscus, ligament or osteochondral pathology * Knee tendinitis or bursitis * Neurologic disease * Pregnancy * Antidepressant therapy or behavioral disorder * Patient unable to comply the required maximum observance * Impossibility to give enlightened information to the patient * Patient under guardianship

Design outcomes

Primary

MeasureTime frame
Item Pain of the KOOS ScoreTwice : at inclusion and at 10 weeks follow-up with feet orthoses

Secondary

MeasureTime frameDescription
KOOS Score (items Symptoms, Activities of daily living, Sport and recreation function, Knee-related quality of life)Twice : at inclusion and at 10 weeks follow-up with feet orthoses
Kujala ScoreTwice : at inclusion and at 10 weeks follow-up with feet orthoses
Pain levelTwice : at inclusion and at 10 weeks follow-up with feet orthosesVisual Analog Scale (VAS)

Countries

France

Contacts

Primary ContactYann DIESINGER, MD
yann.diesinger@chru-strasbourg.fr388552310

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026